Trajectory of care and use of multimodality therapy in older patients with pancreatic adenocarcinoma

Keyphrases

• Pancreatic Adenocarcinoma 100%
• Older Patients 100%
• Combined Modality Therapy 100%
• Care Trajectory 100%
• Chemotherapy 81%
• Resection 72%
• Locoregional 36%
• Initial Treatment 27%
• Treatment Modalities 27%
• Pancreatic Cancer 27%
• Neoadjuvant Setting 27%
• 2-year Survival 18%
• Chemotherapy Alone 18%
• Logistic Regression 9%
• Operative 9%
• Year of Diagnosis 9%
• Surveillance Epidemiology 9%
• Neoadjuvant 9%
• Comorbidity 9%
• Treatment Timing 9%
• Log-rank Test 9%
• Treatment Type 9%
• Microvascular Invasion 9%
• Chemotherapy Duration 9%
• Pancreatic Resection 9%
• Medicare Data 9%
• White Race 9%

Medicine and Dentistry

• Surgery 100%
• Pancreas Adenocarcinoma 100%
• Pancreas Cancer 33%
• Logistic Regression Analysis 11%
• Surveillance, Epidemiology, and End Results 11%
• Medicare 11%
• Log Rank Test 11%